[Preliminary clinical experience on use of a new spasmolytic-analgesic: baralgin].
D000700:Analgesics; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D058633:Antipyretics; D001577:Benzophenones; D004177:Dipyrone; D004338:Drug Combinations; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010276:Parasympatholytics; D010880:Piperidines; D014551:Urinary Tract; D014570:Urologic Diseases
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D001577:Benzophenones; D004338:Drug Combinations; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D010880:Piperidines; D004177:Dipyrone; C002416:fenpiverinium bromide, pitofenone hydrochloride, dipyrone drug combination
ANALGESICS AND ANTIPYRETICS/therapeutic use; MUSCLE RELAXANTS/therapeutic use; URINARY TRACT/diseases
Prime esperienze cliniche sull'uso di un nuovo spasmolitico-analgesico: il baralgin.